Want to join the conversation?
$BIIB 2Q15 Call: In the US total market growth in switch rates remained lower than original expectations. Expects AVONEX and PLEGRIDY will continue to play an important role. TYSABRI demonstrated positive patient growth in 2Q15. ALPROLIX and ELOCTATE continue to grow market share in the US; strong initial uptake in Japan.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.